Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.54% |
| 2 | Technology | 10.66% |
| 3 | Financials | 10.63% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Industrials | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EMKR
2726
DELISTED
Emcore Corp
EMKR
| $1.21M | ﹤0.01% |
33,057
+7,607
| +30% | +$324K |
|
|
BSTC
2727
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $1.2M | ﹤0.01% |
19,300
-1,689
| -8% | -$112K |
|
2728
The RMR Group
RMR
$326M
| $1.2M | ﹤0.01% |
+19,660
| New | +$1.3M |
|
|
HARP
2729
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $1.2M | ﹤0.01% |
+12,666
| New | +$1.66M |
|
2730
Regional Management Corp
RM
$299M
| $1.2M | ﹤0.01% |
49,011
-34,286
| -41% | -$913K |
|
2731
Alamos Gold
AGI
$11.7B
| $1.2M | ﹤0.01% |
235,229
-789,020
| -77% | -$3.6M |
|
|
ACBI
2732
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $1.19M | ﹤0.01% |
66,923
-376,111
| -85% | -$6.94M |
|
|
HAYN
2733
DELISTED
Haynes International, Inc.
HAYN
| $1.19M | ﹤0.01% |
36,243
+3,458
| +11% | +$112K |
|
|
SBBP
2734
DELISTED
Strongbridge Biopharma plc.
SBBP
| $1.18M | ﹤0.01% |
237,776
+74,791
| +46% | +$368K |
|
2735
Pool Corp
POOL
$6.79B
| $1.18M | ﹤0.01% |
7,168
+1,197
| +20% | +$186K |
|
2736
Crocs
CROX
$6.21B
| $1.18M | ﹤0.01% |
45,891
-701,998
| -94% | -$19.2M |
|
2737
CALL
Medpace
MEDP
$15.9B
| $1.18M | ﹤0.01% |
20,000
+10,000
| +100% | +$597K |
|
2738
CALL
Glaukos
GKOS
$9.87B
| $1.18M | ﹤0.01% |
15,000
+10,000
| +200% | +$668K |
|
2739
PUT
Ares Capital
ARCC
$13.4B
| $1.17M | ﹤0.01% |
+68,500
| New | +$1.15M |
|
2740
Blackrock
BLK
$170B
| $1.17M | ﹤0.01% |
2,745
-118,159
| -98% | -$49.6M |
|
2741
Marker Therapeutics
MRKR
$19.2M
| $1.17M | ﹤0.01% |
+17,758
| New | +$1.04M |
|
2742
IDT Corp
IDT
$1.62B
| $1.17M | ﹤0.01% |
176,386
+58,929
| +50% | +$393K |
|
2743
PUT
Walmart Inc
WMT
$887B
| $1.17M | ﹤0.01% |
+36,000
| New | +$1.17M |
|
2744
iShares MSCI Qatar ETF
QAT
$63.6M
| $1.17M | ﹤0.01% |
62,960
+21,688
| +53% | +$404K |
|
2745
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
| $1.16M | ﹤0.01% |
23,197
-10,306
| -31% | -$505K |
|
|
MFNC
2746
DELISTED
Mackinac Financial Corporation
MFNC
| $1.16M | ﹤0.01% |
+73,902
| New | +$1.14M |
|
2747
MaxLinear
MXL
$6.17B
| $1.16M | ﹤0.01% |
+45,492
| New | +$995K |
|
|
CYBE
2748
DELISTED
Cyberoptics Corp
CYBE
| $1.16M | ﹤0.01% |
67,903
+23,676
| +54% | +$469K |
|
|
PHAS
2749
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $1.16M | ﹤0.01% |
121,979
-11,043
| -8% | -$43.7K |
|
2750
AutoZone
AZO
$49.3B
| $1.16M | ﹤0.01% |
1,130
-211,062
| -99% | -$189M |
|
Similar funds
Millennium Management's Q1 2019 Portfolio in Review
As of Q1 2019, Millennium Management held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Millennium Management withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Zimmer Biomet worth $232M.
- Millennium Management's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Millennium Management added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Millennium Management's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Millennium Management fully exited Merck in Q1 2019, selling an estimated $375M.
- Millennium Management's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Millennium Management opened 914 new positions and closed 675 in Q1 2019.
- Millennium Management's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.